🎉 M&A multiples are live!
Check it out!

European Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for European Medical and similar public comparables like CSL, GSK India, and Imugene.

European Medical Overview

About European Medical

European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.


Founded

1997

HQ

Belgium
Employees

20

Website

dms-imaging.com

Financials

Last FY Revenue $45.6M

Last FY EBITDA $2.3M

EV

$38.2M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

European Medical Financials

In the most recent fiscal year, European Medical achieved revenue of $45.6M and an EBITDA of $2.3M.

European Medical expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See European Medical valuation multiples based on analyst estimates

European Medical P&L

NTM Last FY FY 2025 FY 2026 FY 2027
Revenue XXX $45.6M XXX XXX XXX
Gross Profit XXX $15.2M XXX XXX XXX
Gross Margin XXX 33% XXX XXX XXX
EBITDA XXX $2.3M XXX XXX XXX
EBITDA Margin XXX 5% XXX XXX XXX
EBIT XXX $17K XXX XXX XXX
EBIT Margin XXX 0% XXX XXX XXX
Net Profit XXX -$0.8M XXX XXX XXX
Net Margin XXX -2% XXX XXX XXX
Net Debt XXX $11.6M XXX XXX XXX

Financial data powered by Morningstar, Inc.

European Medical Stock Performance

As of May 30, 2025, European Medical's stock price is EUR 4 (or $5).

European Medical has current market cap of EUR 18.6M (or $20.9M), and EV of EUR 34.0M (or $38.2M).

See European Medical trading valuation data

European Medical Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$38.2M $20.9M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

European Medical Valuation Multiples

As of May 30, 2025, European Medical has market cap of $20.9M and EV of $38.2M.

European Medical's trades at 0.8x EV/Revenue multiple, and 16.8x EV/EBITDA.

Equity research analysts estimate European Medical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

European Medical's P/E ratio is not available.

See valuation multiples for European Medical and 12K+ public comps

European Medical Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $20.9M XXX $20.9M XXX XXX XXX
EV (current) $38.2M XXX $38.2M XXX XXX XXX
EV/Revenue n/a XXX 0.8x XXX XXX XXX
EV/EBITDA n/a XXX 16.8x XXX XXX XXX
EV/EBIT n/a XXX 2268.3x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E n/a XXX -26.3x XXX XXX XXX
EV/FCF n/a XXX -7.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get European Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

European Medical Margins & Growth Rates

European Medical's revenue per employee in the last FY averaged $2.3M, while opex per employee averaged $0.8M for the same period.

European Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

European Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for European Medical and other 12K+ public comps

European Medical Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth n/a XXX n/a XXX XXX XXX
EBITDA Margin n/a XXX 5% XXX XXX XXX
EBITDA Growth n/a XXX n/a XXX XXX XXX
Rule of 40 n/a XXX n/a XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX $2.3M XXX XXX XXX
Opex per Employee XXX XXX $0.8M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 1% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 0% XXX XXX XXX
Opex to Revenue XXX XXX 33% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

European Medical Public Comps

See public comps and valuation multiples for Vaccines & Immunotherapies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
CSL XXX XXX XXX XXX XXX XXX
Imugene XXX XXX XXX XXX XXX XXX
Prescient Therapeutics XXX XXX XXX XXX XXX XXX
GSK India XXX XXX XXX XXX XXX XXX
AstraZeneca India XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

European Medical M&A and Investment Activity

European Medical acquired  XXX companies to date.

Last acquisition by European Medical was  XXXXXXXX, XXXXX XXXXX XXXXXX . European Medical acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by European Medical

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About European Medical

When was European Medical founded? European Medical was founded in 1997.
Where is European Medical headquartered? European Medical is headquartered in Belgium.
How many employees does European Medical have? As of today, European Medical has 20 employees.
Is European Medical publicy listed? Yes, European Medical is a public company listed on BRU.
What is the stock symbol of European Medical? European Medical trades under ALEMS ticker.
When did European Medical go public? European Medical went public in 2016.
Who are competitors of European Medical? Similar companies to European Medical include e.g. CSL, Imugene, Prescient Therapeutics, GSK India.
What is the current market cap of European Medical? European Medical's current market cap is $20.9M
Is European Medical profitable? Yes, European Medical is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.